Eloxx Pharmaceuticals, Inc.
Nasdaq ELOX · Arlington, MA
Works in Dermatology · Genetic & rare · GI & liver · Renal & urogenital · Respiratory · Women's health
Eloxx Pharmaceuticals, Inc. is a clinical trial sponsor based in Arlington, MA, listed as Nasdaq ELOX. It has 1 active clinical trial with 24 planned participants, across 6 therapeutic areas. Since 2021 it has completed 6 trials and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq ELOX
Fundraising
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Eloxx Pharmaceuticals, Inc
Eloxx Pharmaceuticals, Inc is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 24 planned participants, in Dermatology, Genetic & rare, GI & liver, Renal & urogenital and other areas. Since 2021 it has completed 6 trials and stopped 0 early.
Eloxx Pharmaceuticals, Inc is based in Arlington, MA and is listed as Nasdaq ELOX. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Eloxx Pharmaceuticals, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-30.
Approve Suite is not affiliated with Eloxx Pharmaceuticals, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.